| T. Rowe Price Capital Appreciation | PRWCX | 34,74 | -1,11% | 32,81B | 30/04 | |
| T. Rowe Price Blue Chip Growth | TRBCX | 163,61 | -1,69% | 29,76B | 30/04 | |
| T. Rowe Price Blue Chip Growth I | TBCIX | 164,56 | -1,68% | 26,17B | 30/04 | |
| T. Rowe Price Capital Appreciation I | TRAIX | 34,75 | -1,08% | 26B | 30/04 | |
| T. Rowe Price Instl Large Cap Growth | TRLGX | 71,19 | -1,67% | 20,44B | 30/04 | |
| T. Rowe Price Growth Stock I | PRUFX | 92,85 | -1,79% | 13,95B | 30/04 | |
| T. Rowe Price Mid-Cap Growth I | RPTIX | 102,41 | -1,60% | 12,5B | 30/04 | |
| T. Rowe Price Mid-Cap Growth | RPMGX | 102,15 | -1,62% | 12,39B | 30/04 | |
| T. Rowe Price Growth Stock | PRGFX | 92,53 | -1,79% | 12,32B | 30/04 | |
| T. Rowe Price Dividend Growth | PRDGX | 73,93 | -1,14% | 12,51B | 30/04 | |
| T. Rowe Price New Horizons I | PRJIX | 54,81 | -1,77% | 11,24B | 30/04 | |
| T. Rowe Price Dividend Growth I | PDGIX | 73,90 | -1,14% | 10,81B | 30/04 | |
| T. Rowe Price New Horizons | PRNHX | 54,47 | -1,77% | 9,58B | 30/04 | |
| T. Rowe Price Health Sciences | PRHSX | 90,17 | -0,06% | 8,83B | 30/04 | |
| T. Rowe Price Equity Index 500 I | PRUIX | 132,53 | -1,57% | 8,86B | 30/04 | |
| T. Rowe Price Equity Income | PRFDX | 35,41 | -1,34% | 8,53B | 30/04 | |
| T. Rowe Price Equity Income I | REIPX | 35,38 | -1,34% | 8,01B | 30/04 | |
| T. Rowe Price Equity Index 500 | PREIX | 132,51 | -1,57% | 7,66B | 30/04 | |
| T. Rowe Price New America Growth | PRWAX | 69,42 | -1,50% | 7,19B | 30/04 | |
| T. Rowe Price Overseas Stock | TROSX | 12,67 | -1,09% | 5,69B | 30/04 | |